Allarity Therapeutics, Inc. (ALLR) has shared an update.
Allarity Therapeutics, Inc. has announced that its Board of Directors has approved a reverse stock split, scheduled to take place on April 9, 2024. For every 20 shares of the company’s common stock owned, shareholders will receive one consolidated share. This move is aimed at restructuring the share distribution without altering the par value of the stock, as the company continues to adapt to market conditions.
Find detailed analytics on ALLR stock on TipRanks’ Stock Analysis page.
